Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions.
Medical Tourism for CCSVI Procedures in People with Multiple Sclerosis: An Observational Study.
Improving drug delivery technology for treating neurodegenerative diseases.
A review on ROCK-II inhibitors: From molecular modelling to synthesis.
Managing Disability in Progressive Multiple Sclerosis.
The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases.
Errata-corrige. Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis.
Pediatric Multiple Sclerosis: Current Concepts and Consensus Definitions.
[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis].
Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores.
Diffusion tensor imaging of optic nerve and optic radiation in primary chronic angle-closure glaucoma using 3T magnetic resonance imaging.
Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
Preliminary validation of the short physical performance battery in older adults with multiple sclerosis: secondary data analysis.
A machine learning pipeline for multiple sclerosis course detection from clinical scales and patient reported outcomes.
Validation of an Arabic version of Fatigue Severity Scale.
Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits.
2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course?
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
Long-term follow-up of immunotherapy-unresponsive recurrent tumefactive demyelination.
A cytoarchitecture-driven myelin model reveals area-specific signatures in human primary and secondary areas using ultra-high resolution in-vivo brain MRI.

Pages